India's drug regulator has banned cosmetic injections amid a surge in adverse reactions, including deaths and rare immune responses, linked to unregulated beauty injections administered outside proper medical settings.
India arrived at the 79th World Health Assembly in Geneva not only as a participant but also as a model for the AI healthcare revolution.
Dr Reddy’s launches oral semaglutide Obeda in India, expanding treatment options for people living with Type 2 diabetes and marking an important step in making advanced diabetes care more accessible. The Hyderabad-based pharmaceutical compa...
India tightens Ebola vigilance with no cases reported yet amid the WHO alert, as the Centre steps up preparedness measures following the World Health Organization (WHO)’s declaration of a global health emergency. While officials have confirme...
Meghalaya Sets New Benchmark in Public Healthcare System as the state pushes ahead with reforms, quality certification, and stronger public service delivery across districts. The phrase Meghalaya is central to this health story, and it captures...
India-US cooperation is rapidly becoming a key driver of innovation in biotech and healthcare, with both nations expanding partnerships in biotechnology, nuclear medicine, advanced research, and healthcare technology.
India plans national registry to track implantable medical devices and patients as the government moves to strengthen oversight in the healthcare sector and improve patient safety. The proposed system is expected to create a centralized databa...
Parexel has launched ParexelAI, a proprietary suite of human-led AI services and capabilities designed to improve speed, quality, and efficiency across the clinical development lifecycle for the life sciences industry.
Apollo HomeCare and Apollo AyurVAID have partnered to launch an integrated Transition Care service aimed at addressing the gap patients often face between hospital discharge and safely returning home.
Zydus Lifesciences is preparing for a major international expansion of its semaglutide business, with plans to roll out the drug across more than 20 markets over the next two years. The company is also betting on a sharp scale-up of its biosimil...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")